Literature DB >> 34117868

The Incubation Period Distribution of Coronavirus Disease 2019: A Systematic Review and Meta-analysis.

Hualei Xin1, Jessica Y Wong1, Caitriona Murphy1, Amy Yeung1, Sheikh Taslim Ali1,2, Peng Wu1,2, Benjamin J Cowling1,2.   

Abstract

Incubation period is an important parameter to inform quarantine period and to study transmission dynamics of infectious diseases. We conducted a systematic review and meta-analysis on published estimates of the incubation period distribution of coronavirus disease 2019, and showed that the pooled median of the point estimates of the mean, median and 95th percentile for incubation period are 6.3 days (range, 1.8-11.9 days), 5.4 days (range, 2.0-17.9 days), and 13.1 days (range, 3.2-17.8 days), respectively. Estimates of the mean and 95th percentile of the incubation period distribution were considerably shorter before the epidemic peak in China compared to after the peak, and variation was also noticed for different choices of methodological approach in estimation. Our findings implied that corrections may be needed before directly applying estimates of incubation period into control of or further studies on emerging infectious diseases.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; incubation period; meta-analysis; systematic review

Mesh:

Year:  2021        PMID: 34117868     DOI: 10.1093/cid/ciab501

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

1.  COVID-19 in Japan, January-March 2020: insights from the first three months of the epidemic.

Authors:  Natsuko Imai; Katy A M Gaythorpe; Sangeeta Bhatia; Tara D Mangal; Gina Cuomo-Dannenburg; H Juliette T Unwin; Elita Jauneikaite; Neil M Ferguson
Journal:  BMC Infect Dis       Date:  2022-05-25       Impact factor: 3.667

Review 2.  Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.

Authors:  William R Strohl; Zhiqiang Ku; Zhiqiang An; Stephen F Carroll; Bruce A Keyt; Lila M Strohl
Journal:  BioDrugs       Date:  2022-04-27       Impact factor: 7.744

3.  Transmission and containment of the SARS-CoV-2 Delta variant of concern in Guangzhou, China: A population-based study.

Authors:  Li Li; Zhi-Gang Han; Peng-Zhe Qin; Wen-Hui Liu; Zhou Yang; Zong-Qiu Chen; Ke Li; Chao-Jun Xie; Yu Ma; Hui Wang; Yong Huang; Shu-Jun Fan; Ze-Lin Yan; Chun-Quan Ou; Lei Luo
Journal:  PLoS Negl Trop Dis       Date:  2022-01-05

4.  Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Postexposure Prophylaxis of COVID-19 in Hospital Personnel Dedicated to Patients Care with COVID-19 Disease.

Authors:  Juan Manuel Figueroa; Mónica Edith Lombardo; Ariel Dogliotti; Luis Pedro Flynn; Robert Giugliano; Guido Simonelli; Ricardo Valentini; Agñel Ramos; Pablo Romano; Marcelo Marcote; Alicia Michelini; Alejandro Salvado; Emilio Sykora; Cecilia Kniz; Marcelo Kobelinsky; David Manuel Salzberg; Diana Jerusalinsky; Osvaldo Uchitel
Journal:  Int J Gen Med       Date:  2021-10-01

5.  Effectiveness of 14 day quarantine strategy: Chinese experience of prevention and control.

Authors:  Hongwei Tu; Keqi Hu; Meng Zhang; Yali Zhuang; Tie Song
Journal:  BMJ       Date:  2021-12-01

6.  Waning of SARS-CoV-2 booster viral-load reduction effectiveness.

Authors:  Matan Levine-Tiefenbrun; Idan Yelin; Hillel Alapi; Esma Herzel; Jacob Kuint; Gabriel Chodick; Sivan Gazit; Tal Patalon; Roy Kishony
Journal:  Nat Commun       Date:  2022-03-04       Impact factor: 14.919

7.  Reassessing Reported Deaths and Estimated Infection Attack Rate during the First 6 Months of the COVID-19 Epidemic, Delhi, India.

Authors:  Margarita Pons-Salort; Jacob John; Oliver J Watson; Nicholas F Brazeau; Robert Verity; Gagandeep Kang; Nicholas C Grassly
Journal:  Emerg Infect Dis       Date:  2022-02-25       Impact factor: 6.883

8.  Shorter Incubation Period among Unvaccinated Delta Variant Coronavirus Disease 2019 Patients in Japan.

Authors:  Tsuyoshi Ogata; Hideo Tanaka; Fujiko Irie; Atsushi Hirayama; Yuki Takahashi
Journal:  Int J Environ Res Public Health       Date:  2022-01-20       Impact factor: 3.390

9.  Effect of Non-lockdown Social Distancing and Testing-Contact Tracing During a COVID-19 Outbreak in Daegu, South Korea, February to April 2020: A Modeling Study.

Authors:  Yi-Hsuan Chen; Chi-Tai Fang; Yu-Ling Huang
Journal:  Int J Infect Dis       Date:  2021-07-29       Impact factor: 3.623

10.  Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021.

Authors:  Min Kang; Hualei Xin; Jun Yuan; Sheikh Taslim Ali; Zimian Liang; Jiayi Zhang; Ting Hu; Eric Hy Lau; Yingtao Zhang; Meng Zhang; Benjamin J Cowling; Yan Li; Peng Wu
Journal:  Euro Surveill       Date:  2022-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.